Observational studyViruses2022

Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak.

Arianna Sonaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.